CMAX Clinical Research is an independent clinical research facility, based in Adelaide, Australia. CMAX has been established as a Phase I unit since December 1993, making it the longest-running in Australia and, since establishment, has consistently maintained world class standards with a total commitment to providing excellence and quality in all areas of clinical service. CMAX is also one of Australia’s most modern Phase I clinical facilities, adjacent to Adelaide’s Biomed City. The facility offers 78‐bed capacity for in‐house stays and conducts >40 studies per year. The CMAX site specialises in Phase I – FTIH, SAD/MAD, first time in patients, BA/BE, PK/PD and Proof-Of-Concept studies. CMAX has conducted >600 studies since the unit was established.





